{"DataElement":{"publicId":"6686527","version":"1","preferredName":"Retroperitoneal Soft Tissue Sarcoma AJCC Edition 8 Group Stage","preferredDefinition":"Stage group based on the combination of T, N, and M categories and relevant prognostic factors for soft tissue sarcoma of the retroperitoneum using AJCC Ed. 8 criteria.","longName":"STSRP_AJC8_DZ_STG","context":"NCI Standards","contextVersion":"1","DataElementConcept":{"publicId":"6686516","version":"1","preferredName":"Retroperitoneum Soft Tissue Sarcoma Stage Grouping","preferredDefinition":"The back of the abdomen where the kidneys lie and the great blood vessels run._A malignant neoplasm arising from muscle tissue, adipose tissue, blood vessels, fibrous tissue, or other supportive tissues excluding the bones._An assessment based on the combined evaluation of the patient's T stage, M stage, and N stage, as well as prognostic parameters for specific cancers.","longName":"6686502v1.0:2230143v1.0","context":"NCI Standards","contextVersion":"1","ObjectClass":{"publicId":"6686502","version":"1","preferredName":"Retroperitoneum Soft Tissue Sarcoma","preferredDefinition":"The back of the abdomen where the kidneys lie and the great blood vessels run.:A malignant neoplasm arising from muscle tissue, adipose tissue, blood vessels, fibrous tissue, or other supportive tissues excluding the bones.","longName":"C12298:C9306","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Retroperitoneum","conceptCode":"C12298","definition":"The back of the abdomen where the kidneys lie and the great blood vessels run.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Soft Tissue Sarcoma","conceptCode":"C9306","definition":"A malignant neoplasm arising from muscle tissue, adipose tissue, blood vessels, fibrous tissue, or other supportive tissues excluding the bones.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"85A6CB06-47B1-4BE3-E053-F662850ABCF5","latestVersionIndicator":"Yes","beginDate":"2019-04-03","endDate":null,"createdBy":"TAYLORT","dateCreated":"2019-04-03","modifiedBy":"ONEDATA","dateModified":"2019-04-03","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2230143","version":"1","preferredName":"Stage Grouping","preferredDefinition":"Stage Grouping; an assessment based on the combined evaluation of the patient's T stage, M stage, and N stage. (caDSR)","longName":"C38027","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stage Grouping","conceptCode":"C38027","definition":"An assessment based on the combined evaluation of the patient's T stage, M stage, and N stage, as well as prognostic parameters for specific cancers.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F752037A-4CC2-36A8-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-05-18","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-05-18","modifiedBy":"ONEDATA","dateModified":"2005-05-18","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"AJCC Based:Staging Criteria Based on American Joint Committee on Cancer System","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"85A6E2F5-1AD2-4672-E053-F662850AEF4C","latestVersionIndicator":"Yes","beginDate":"2019-04-03","endDate":null,"createdBy":"TAYLORT","dateCreated":"2019-04-03","modifiedBy":"TAYLORT","dateModified":"2022-02-24","changeDescription":"TL released; 2/24/22.; 4-3-19 created for standardization; tmt.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"6686486","version":"1","preferredName":"Soft Tissue Sarcoma Retroperitoneum American Joint Committee on Cancer Edition 8 Group Stage","preferredDefinition":"A term that refers to the staging of retroperitoneal soft tissue sarcoma, following the rules of the TNM AJCC v8 classification system. This staging system applies to common sarcomas in the retroperitoneum. (from AJCC 8th Ed.)_An assessment based on the combined evaluation of the patient's T stage, M stage, and N stage, as well as prognostic parameters for specific cancers._The extent of a cancer in the body. Staging is usually based on the size of the tumor, whether lymph nodes contain cancer, and whether the cancer has spread from the original site to other parts of the body.","longName":"6686486v1.0","context":"NCI Standards","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":"2","maxLength":"4","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"IV","valueDescription":"Stage IV Retroperitoneal Sarcoma AJCC v8","ValueMeaning":{"publicId":"6686488","version":"1","preferredName":"Stage IV Retroperitoneal Sarcoma AJCC v8","longName":"6686488","preferredDefinition":"Stage IV includes: Any T, Any N, M1, Any G. M1: Distant metastasis. (AJCC 8th ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stage IV Retroperitoneal Sarcoma AJCC v8","conceptCode":"C136819","definition":"Stage IV includes: Any T, Any N, M1, Any G. M1: Distant metastasis. (AJCC 8th ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"85A6626C-A5AE-4532-E053-F662850A32DE","latestVersionIndicator":"Yes","beginDate":"2019-04-03","endDate":null,"createdBy":"TAYLORT","dateCreated":"2019-04-03","modifiedBy":"ONEDATA","dateModified":"2019-04-03","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"85A6626C-A5C7-4532-E053-F662850A32DE","beginDate":"2019-04-03","endDate":null,"createdBy":"TAYLORT","dateCreated":"2019-04-03","modifiedBy":"ONEDATA","dateModified":"2019-04-03","deletedIndicator":"No"},{"value":"IIIB","valueDescription":"Stage IIIB Retroperitoneal Sarcoma AJCC v8","ValueMeaning":{"publicId":"6686490","version":"1","preferredName":"Stage IIIB Retroperitoneal Sarcoma AJCC v8","longName":"6686490","preferredDefinition":"Stage IIIB includes: (T3, T4, N0, M0, G2, G3); (Any T, N1, M0, Any G). T3: Tumor measuring more than 10 cm and less than or equal to 15 cm in greatest dimension. T4: Tumor measuring more than 15 cm in greatest dimension. N0: No regional lymph node metastasis or unknown lymph node status. N1: Regional lymph node metastasis. M0: No distant metastasis. G2: Total differentiation, mitotic count and necrosis score of 4 or 5. G3: Total differentiation, mitotic count and necrosis score of 6, 7, or 8. (AJCC 8th ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stage IIIB Retroperitoneal Sarcoma AJCC v8","conceptCode":"C136818","definition":"Stage IIIB includes: (T3, T4, N0, M0, G2, G3); (Any T, N1, M0, Any G). T3: Tumor measuring more than 10 cm and less than or equal to 15 cm in greatest dimension. T4: Tumor measuring more than 15 cm in greatest dimension. N0: No regional lymph node metastasis or unknown lymph node status. N1: Regional lymph node metastasis. M0: No distant metastasis. G2: Total differentiation, mitotic count and necrosis score of 4 or 5. G3: Total differentiation, mitotic count and necrosis score of 6, 7, or 8. (AJCC 8th ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"85A6626C-A5D4-4532-E053-F662850A32DE","latestVersionIndicator":"Yes","beginDate":"2019-04-03","endDate":null,"createdBy":"TAYLORT","dateCreated":"2019-04-03","modifiedBy":"ONEDATA","dateModified":"2019-04-03","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"85A6626C-A5ED-4532-E053-F662850A32DE","beginDate":"2019-04-03","endDate":null,"createdBy":"TAYLORT","dateCreated":"2019-04-03","modifiedBy":"ONEDATA","dateModified":"2019-04-03","deletedIndicator":"No"},{"value":"IIIA","valueDescription":"Stage IIIA Retroperitoneal Sarcoma AJCC v8","ValueMeaning":{"publicId":"6686492","version":"1","preferredName":"Stage IIIA Retroperitoneal Sarcoma AJCC v8","longName":"6686492","preferredDefinition":"Stage IIIA includes: T2, N0, M0, G2, G3. T2: Tumor measuring more than 5 cm and less than or equal to 10 cm in greatest dimension. N0: No regional lymph node metastasis or unknown lymph node status. M0: No distant metastasis. G2: Total differentiation, mitotic count and necrosis score of 4 or 5. G3: Total differentiation, mitotic count and necrosis score of 6, 7, or 8. (AJCC 8th ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stage IIIA Retroperitoneal Sarcoma AJCC v8","conceptCode":"C136817","definition":"Stage IIIA includes: T2, N0, M0, G2, G3. T2: Tumor measuring more than 5 cm and less than or equal to 10 cm in greatest dimension. N0: No regional lymph node metastasis or unknown lymph node status. M0: No distant metastasis. G2: Total differentiation, mitotic count and necrosis score of 4 or 5. G3: Total differentiation, mitotic count and necrosis score of 6, 7, or 8. (AJCC 8th ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"85A6626C-A5FA-4532-E053-F662850A32DE","latestVersionIndicator":"Yes","beginDate":"2019-04-03","endDate":null,"createdBy":"TAYLORT","dateCreated":"2019-04-03","modifiedBy":"ONEDATA","dateModified":"2019-04-03","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"85A6626C-A613-4532-E053-F662850A32DE","beginDate":"2019-04-03","endDate":null,"createdBy":"TAYLORT","dateCreated":"2019-04-03","modifiedBy":"ONEDATA","dateModified":"2019-04-03","deletedIndicator":"No"},{"value":"II","valueDescription":"Stage II Retroperitoneal Sarcoma AJCC v8","ValueMeaning":{"publicId":"6686494","version":"1","preferredName":"Stage II Retroperitoneal Sarcoma AJCC v8","longName":"6686494","preferredDefinition":"Stage II includes: T1, N0, M0, G2, G3. T1: Tumor measuring 5 cm or less in greatest dimension. N0: No regional lymph node metastasis or unknown lymph node status. M0: No distant metastasis. G2: Total differentiation, mitotic count and necrosis score of 4 or 5. G3: Total differentiation, mitotic count and necrosis score of 6, 7, or 8. (AJCC 8th ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stage II Retroperitoneal Sarcoma AJCC v8","conceptCode":"C136815","definition":"Stage II includes: T1, N0, M0, G2, G3. T1: Tumor measuring 5 cm or less in greatest dimension. N0: No regional lymph node metastasis or unknown lymph node status. M0: No distant metastasis. G2: Total differentiation, mitotic count and necrosis score of 4 or 5. G3: Total differentiation, mitotic count and necrosis score of 6, 7, or 8. (AJCC 8th ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"85A6626C-A620-4532-E053-F662850A32DE","latestVersionIndicator":"Yes","beginDate":"2019-04-03","endDate":null,"createdBy":"TAYLORT","dateCreated":"2019-04-03","modifiedBy":"ONEDATA","dateModified":"2019-04-03","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"85A6626C-A639-4532-E053-F662850A32DE","beginDate":"2019-04-03","endDate":null,"createdBy":"TAYLORT","dateCreated":"2019-04-03","modifiedBy":"ONEDATA","dateModified":"2019-04-03","deletedIndicator":"No"},{"value":"IB","valueDescription":"Stage IB Retroperitoneal Sarcoma AJCC v8","ValueMeaning":{"publicId":"6686496","version":"1","preferredName":"Stage IB Retroperitoneal Sarcoma AJCC v8","longName":"6686496","preferredDefinition":"Stage IB includes: T2, T3, T4, N0, M0, G1, GX. T2: Tumor measuring more than 5 cm and less than or equal to 10 cm in greatest dimension. T3: Tumor measuring more than 10 cm and less than or equal to 15 cm in greatest dimension. T4: Tumor measuring more than 15 cm in greatest dimension. N0: No regional lymph node metastasis or unknown lymph node status. M0: No distant metastasis. GX: Grade cannot be assessed. G1: Total differentiation, mitotic count and necrosis score of 2 or 3. (AJCC 8th ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stage IB Retroperitoneal Sarcoma AJCC v8","conceptCode":"C136814","definition":"Stage IB includes: T2, T3, T4, N0, M0, G1, GX. T2: Tumor measuring more than 5 cm and less than or equal to 10 cm in greatest dimension. T3: Tumor measuring more than 10 cm and less than or equal to 15 cm in greatest dimension. T4: Tumor measuring more than 15 cm in greatest dimension. N0: No regional lymph node metastasis or unknown lymph node status. M0: No distant metastasis. GX: Grade cannot be assessed. G1: Total differentiation, mitotic count and necrosis score of 2 or 3. (AJCC 8th ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"85A6626C-A646-4532-E053-F662850A32DE","latestVersionIndicator":"Yes","beginDate":"2019-04-03","endDate":null,"createdBy":"TAYLORT","dateCreated":"2019-04-03","modifiedBy":"ONEDATA","dateModified":"2019-04-03","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"85A6626C-A65F-4532-E053-F662850A32DE","beginDate":"2019-04-03","endDate":null,"createdBy":"TAYLORT","dateCreated":"2019-04-03","modifiedBy":"ONEDATA","dateModified":"2019-04-03","deletedIndicator":"No"},{"value":"IA","valueDescription":"Stage IA Retroperitoneal Sarcoma AJCC v8","ValueMeaning":{"publicId":"6686498","version":"1","preferredName":"Stage IA Retroperitoneal Sarcoma AJCC v8","longName":"6686498","preferredDefinition":"Stage IA includes: T1, N0, M0, G1, GX. T1: Tumor measuring 5 cm or less in greatest dimension. N0: No regional lymph node metastasis or unknown lymph node status. M0: No distant metastasis. GX: Grade cannot be assessed. G1: Total differentiation, mitotic count and necrosis score of 2 or 3. (AJCC 8th ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stage IA Retroperitoneal Sarcoma AJCC v8","conceptCode":"C136813","definition":"Stage IA includes: T1, N0, M0, G1, GX. T1: Tumor measuring 5 cm or less in greatest dimension. N0: No regional lymph node metastasis or unknown lymph node status. M0: No distant metastasis. GX: Grade cannot be assessed. G1: Total differentiation, mitotic count and necrosis score of 2 or 3. (AJCC 8th ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"85A6626C-A66C-4532-E053-F662850A32DE","latestVersionIndicator":"Yes","beginDate":"2019-04-03","endDate":null,"createdBy":"TAYLORT","dateCreated":"2019-04-03","modifiedBy":"ONEDATA","dateModified":"2019-04-03","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"85A6626C-A685-4532-E053-F662850A32DE","beginDate":"2019-04-03","endDate":null,"createdBy":"TAYLORT","dateCreated":"2019-04-03","modifiedBy":"ONEDATA","dateModified":"2019-04-03","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"6686485","version":"1","preferredName":"Retroperitoneal Sarcoma by AJCC v8 Stage Stage Grouping Stage","preferredDefinition":"A term that refers to the staging of retroperitoneal soft tissue sarcoma, following the rules of the TNM AJCC v8 classification system. This staging system applies to common sarcomas in the retroperitoneum. (from AJCC 8th Ed.):An assessment based on the combined evaluation of the patient's T stage, M stage, and N stage, as well as prognostic parameters for specific cancers.:The extent of a cancer in the body. Staging is usually based on the size of the tumor, whether lymph nodes contain cancer, and whether the cancer has spread from the original site to other parts of the body.","longName":"C136811:C38027:C16899","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Retroperitoneal Sarcoma by AJCC v8 Stage","conceptCode":"C136811","definition":"A term that refers to the staging of retroperitoneal soft tissue sarcoma, following the rules of the TNM AJCC v8 classification system. This staging system applies to common sarcomas in the retroperitoneum. (from AJCC 8th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Stage Grouping","conceptCode":"C38027","definition":"An assessment based on the combined evaluation of the patient's T stage, M stage, and N stage, as well as prognostic parameters for specific cancers.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Neoplasm Stage","conceptCode":"C16899","definition":"The extent of a cancer in the body.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"85A6626C-A581-4532-E053-F662850A32DE","latestVersionIndicator":"Yes","beginDate":"2019-04-03","endDate":null,"createdBy":"TAYLORT","dateCreated":"2019-04-03","modifiedBy":"ONEDATA","dateModified":"2019-04-03","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"AJCC Based:Staging Criteria Based on American Joint Committee on Cancer System","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"85A6626C-A592-4532-E053-F662850A32DE","latestVersionIndicator":"Yes","beginDate":"2019-04-03","endDate":null,"createdBy":"TAYLORT","dateCreated":"2019-04-03","modifiedBy":"TAYLORT","dateModified":"2022-02-24","changeDescription":"TL released; 2/24/22.; 4-3-19 created for standardization; tmt.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"5574838","version":"1","longName":"Staging/Extent of Disease","context":"NCI Standards","ClassificationSchemeItems":[{"publicId":"6005920","version":"1","longName":"AJCC Edition 8","context":"NCI Standards"},{"publicId":"6682263","version":"1","longName":"Soft Tissue Sarcomas","context":"NCI Standards"}]}],"AlternateNames":[],"ReferenceDocuments":[{"name":"Disease stage","type":"Preferred Question Text","description":"Disease stage","url":null,"context":"NCI Standards"}],"origin":"AJCC Based:Staging Criteria Based on American Joint Committee on Cancer System","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"85A6DEEF-A224-423B-E053-F662850ACB62","latestVersionIndicator":"Yes","beginDate":"2019-04-03","endDate":null,"createdBy":"TAYLORT","dateCreated":"2019-04-03","modifiedBy":"TAYLORT","dateModified":"2022-02-24","changeDescription":"TL released; 2/24/22.; 4-3-19 created for standardization; tmt.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}